Chronic Lymphocytic Leukemia is a cancer of the white blood cells. It is the mostly widely diagnosed type of leukemia in the Western world, mostly affecting older men and has a poor survival rate. As the Baby Boomer generation grows older, the incidence of CLL will increase.

In the new era of personalized medicine, what new diagnostic tests will improve detection at the earliest stages? What research discoveries will pave the way to new treatments and improve survivorship? What clinical trials are being conducted in Manitoba? Join us in a lively and open discussion on CLL with Canada’s leading scientists, clinicians, patient advocates and nurses on this important disease.